QuidelOrtho Corporation
Research QuidelOrtho Corporation (QDEL) on Bullrun: market cap USD 1.03B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerQDEL
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 1.03B
- Financial periodQ2 2026
- RevenueUSD 630.90M
- Net income-USD 92.90M
- Free cash flow-USD 136.10M
- Gross margin43.3%
Valuation Snapshot
latest market cap is USD 1.03B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 2.73B | -USD 1.13B | -USD 83.00M | 46.7% | -16.69 | USD 169.80M | USD 2.88B | USD 1.92B |
| FY2024 | USD 2.78B | -USD 2.05B | -USD 112.10M | 46.2% | -30.54 | USD 98.30M | USD 2.83B | USD 2.98B |
| FY2023 | USD 3.00B | -USD 10.10M | USD 70.90M | n/a | -0.15 | USD 118.90M | USD 2.56B | USD 5.01B |
| FY2022 | USD 1.70B | USD 704.20M | USD 513.10M | n/a | 16.43 | USD 802.80M | USD 300.00K | USD 1.93B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 1.03B | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 1.94B | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 3.00B | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 4.92B | 387.9 | n/a | n/a |
| 2022 | 2022-12-30 | USD 5.66B | 4.6 | n/a | n/a |
| 2021 | 2021-12-31 | USD 5.63B | 8.2 | n/a | n/a |
About QuidelOrtho Corporation
QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is QuidelOrtho Corporation's market cap?
QuidelOrtho Corporation's market capitalization is USD 1.03B.
What does QuidelOrtho Corporation do?
QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units.